日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 麻豆视频免费看 | 日韩高清久久 | 三级视频在线看 | 国产一区二区三区免费 | 亚洲在线日韩 | 欧美三级影院 | 黄色一级在线 | 午夜影院福利 | 成人午夜免费福利视频 | 久久精品一级片 | 永久免费精品视频 | 视频一区二区三区在线观看 | 黄色大片免费网站 | 在线免费观看亚洲 | 激情视频网站在线观看 | 欧美一级在线 | 亚洲黑丝在线 | 欧美成年人视频 | 超碰在线一区 | 亚洲国产精品尤物yw在线观看 | 国产精品手机视频 | 亚洲欧美日韩成人在线 | 国产日韩视频 | 丰满漂亮的日本岳 | 撸大师在线观看 | 久久精品国产99国产 | 国产成人免费视频 | 欧美日韩在线观看视频 | 你懂的免费在线观看 | 欲色综合 | 国产精品诱惑 | www.亚洲精品| 另类天堂网 | 久久久久久久 | 日本黄色不卡视频 | 三级国产在线观看 | 欧美激情福利 | 日韩在线网 | 久久伊人在 | 日本污视频在线观看 | av有码在线 |